<DOC>
	<DOCNO>NCT02882243</DOCNO>
	<brief_summary>This investigation provide safety effectiveness information use FLXfit™ Cage . Data use Post Market follow-up FLXfit™ system evaluate : - Safety measure rate serious operative post-operative complication . - Patients ' quality life , measure health-related quality life questionnaires 24 month follow procedure , compare patient 's baseline .</brief_summary>
	<brief_title>FLXfit Post Market Outcome Study Protocol</brief_title>
	<detailed_description>Interbody fusion patient degenerative disc disease ( DDD ) one two contiguous level L2 S1 . Patients may also Grade I spondylolisthesis retrolisthesis involve level ( ) . Patients skeletally mature complete six month non-operative treatment</detailed_description>
	<mesh_term>Intervertebral Disc Degeneration</mesh_term>
	<criteria>Adult ( age 18 70 year ) patient ( male female ) follow condition lumbar spine confirm advanced imaging ( CT MRI ) , candidate primary spinal fusion procedure accord acceptable criterion medical condition : Degenerative disc disease With Grade I spondylolisthesis Failure least 6 month conservative treatment BMI &lt; 40 . Patient approve pregnancy 24 month study participation study parallel one . This device intend cervical spine use . PI may exclude patient study Contraindications include , limited : Infection , local operative site Signs local inflammation , Fever leukocytosis , Morbid obesity , Pregnancy , Mental illness , Any condition would preclude potential benefit spinal implant surgery , presence tumor congenital abnormality , fracture local operating site , elevation segmentation rate unexplained disease , elevation white blood count ( WBC ) , mark left shift WBC differential count , Suspected document allergy intolerance implant 's material , Any case describe indication , Any patient unwilling cooperate postoperative instruction . These device must use pediatric case , patient still general skeletal growth . Any case implant component select use would large small achieve successful result . Any patient inadequate tissue coverage operative site inadequate bone stock quality . Any patient implant utilization would interfere anatomical structure expect physiological performance . Prior fusion level treat .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>